No safety concerns observed when the adjuvanted recombinant zoster vaccine (rzv) and the covid-19 mrna-1273 booster were co-administered in ≥50-year-olds
International Journal of Infectious Diseases（2023）
关键词
adjuvanted recombinant zoster vaccine,rzv,co-administered,year-olds
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要